HealthTech
The company designed the device to then automatically titrate and infuse insulin without requiring the counting of carbohydrates, the settings of certain rates and...
Hi, what are you looking for?
TMG360 News
Digital Health
Boston-based Pear struck a deal with SoftBank, a Japan-based communication and information technology service provider, to develop the digital therapeutic for the treatment of...
Emerging Technologies
Instead of a catheter located in a vein, the system has a short extension from the device inserted by a physician into a bone,...
Digital Health
The platform provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks.
BioTechnology
When developing Vuity, Allergan developed 16 eye drop formulations before settling on the now FDA-approved solution.
BioTechnology
The trial found that improvements were seen in VAS dry eye symptoms for both formulations of OTX-DED, with little separation between OTX-DED and the...
Digital Health
The company offers the program as a bundle of devices, supplies and services and delivered as a 30-day subscription to eliminate upfront costs.
Digital Health
Lexington, Massachusetts-based Fractyl Health (formerly Fractyl Laboratories) can now increase the sample size of the Revitalize-1 trial (formerly Revita-T2Di trial) from 288 to 420.
Emerging Technologies
Bexson Biomedical announced today that it received pre-investigational new drug guidance from the FDA for its ketamine compound therapy.
Clinical Trials
Optejet is designed with no protruding parts to prevent the accidental touching of the ocular surface.
